Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,837 papers from all fields of science
Search
Sign In
Create Free Account
Involved-Field Radiation Therapy
Known as:
IFRT
, Involved field radiotherapy
Radiation treatment delivered only to the areas of the body that are affected, used primarily in the treatment of lymphoma.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Involved-field radiation therapy for locoregionally recurrent ovarian cancer.
Aaron P. Brown
,
A. Jhingran
,
A. Klopp
,
K. Schmeler
,
P. Ramirez
,
P. Eifel
Gynecologic Oncology
2013
Corpus ID: 5227919
Review
2007
Review
2007
Involved-field radiation therapy for inoperable non small-cell lung cancer.
K. Rosenzweig
,
S. Sura
,
A. Jackson
,
E. Yorke
Journal of Clinical Oncology
2007
Corpus ID: 25713286
PURPOSE Dose escalation has been shown to improve local control in non-small-cell lung cancer (NSCLC) treated with definitive…
Expand
Highly Cited
2006
Highly Cited
2006
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.
T. Girinsky
,
R. V. D. van der Maazen
,
+7 authors
E. Noordijk
Radiotherapy and Oncology
2006
Corpus ID: 9118963
Highly Cited
2004
Highly Cited
2004
In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.
R. Haas
,
D. de Jong
,
+5 authors
M. Verheij
International Journal of Radiation Oncology…
2004
Corpus ID: 3171498
Highly Cited
2003
Highly Cited
2003
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
R. Haas
,
P. Poortmans
,
+8 authors
H. Bartelink
Journal of Clinical Oncology
2003
Corpus ID: 35827989
PURPOSE To study the response rates and duration of response after low-dose (4 Gy) involved field radiotherapy (LD-IF-RT) in…
Expand
Highly Cited
2002
Highly Cited
2002
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
J. Nachman
,
R. Sposto
,
+8 authors
Keith White
Journal of Clinical Oncology
2002
Corpus ID: 2159578
PURPOSE Current standard therapy for children and adolescents with Hodgkin's disease includes combination chemotherapy and low…
Expand
Highly Cited
2001
Highly Cited
2001
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.
C. Moskowitz
,
S. Nimer
,
+16 authors
J. Yahalom
Blood
2001
Corpus ID: 29279440
Salvage of patients with relapsed and refractory Hodgkin disease (HD) with high-dose chemoradiotherapy (HDT) and autologous stem…
Expand
Highly Cited
1994
Highly Cited
1994
Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution.
G. Biti
,
E. Cellai
,
S. Magrini
,
M. Papi
,
P. Ponticelli
,
V. Boddi
International Journal of Radiation Oncology…
1994
Corpus ID: 25197845
Highly Cited
1992
Highly Cited
1992
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot…
A. Nademanee
,
Schmidt Gm
,
+7 authors
K. Margolin
Blood
1992
Corpus ID: 27067637
Twenty consecutive patients with poor-risk aggressive lymphoma who at presentation either had elevated serum lactic dehydrogenase…
Expand
Highly Cited
1983
Highly Cited
1983
Initial chemotherapy for clinically localized lymphomas of unfavorable histology.
T. Miller
,
Stephen E. Jones
Blood
1983
Corpus ID: 7284775
Forty-five patients with localized non-Hodgkin's lymphoma of unfavorable histologic type (41 patients had diffuse histiocytic, 2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE